Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
August 2, 2014
MDSCs: the final frontier of the microenvironment in CLL?
Katja Zirlik
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Idelalisib
Katja Zirlik, Hendrik Veelken
Oncology Research and Treatment
|
March 22, 2018
Anti-Angiogenics: Current Situation and Future Perspectives
Katja Zirlik, Justus Duyster
Pharmazie in Unserer Zeit
|
April 29, 2010
[Vorinostat in the treatment of cutaneous T-cell lymphomas. Treatment with histone deacetylases inhibitors]
Katja Zirlik, Dorothée Nashan, Hendrik Veelken
Cancer Research
|
April 19, 2006
Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression
Cristina Bertinetti, Katja Zirlik, Kristina Heining-Mikesch, et al.
Molecular Cancer
|
November 25, 2010
Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia
Julie Catusse, Marion Leick, Mareike Groch, et al.
Blood
|
June 5, 2010
Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma
Anna-Maria Strothmeyer, Dimitrios Papaioannou, Marcus Dühren-von Minden, et al.
European Journal of Haematology
|
August 2, 2006
Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli
Cristina Bertinetti, Frederic Simon, Katja Zirlik, et al.
Journal of Surgical Oncology
|
November 27, 2013
Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients
Jens Hoeppner, Katja Zirlik, Thomas Brunner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 3, 2013
Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy
Frank Makowiec, Peter Baier, Birte Kulemann, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
August 2, 2014
MDSCs: the final frontier of the microenvironment in CLL?
Katja Zirlik
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Idelalisib
Katja Zirlik, Hendrik Veelken
Oncology Research and Treatment
|
March 22, 2018
Anti-Angiogenics: Current Situation and Future Perspectives
Katja Zirlik, Justus Duyster
Pharmazie in Unserer Zeit
|
April 29, 2010
[Vorinostat in the treatment of cutaneous T-cell lymphomas. Treatment with histone deacetylases inhibitors]
Katja Zirlik, Dorothée Nashan, Hendrik Veelken
Cancer Research
|
April 19, 2006
Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression
Cristina Bertinetti, Katja Zirlik, Kristina Heining-Mikesch, et al.
Molecular Cancer
|
November 25, 2010
Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia
Julie Catusse, Marion Leick, Mareike Groch, et al.
Blood
|
June 5, 2010
Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma
Anna-Maria Strothmeyer, Dimitrios Papaioannou, Marcus Dühren-von Minden, et al.
European Journal of Haematology
|
August 2, 2006
Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli
Cristina Bertinetti, Frederic Simon, Katja Zirlik, et al.
Journal of Surgical Oncology
|
November 27, 2013
Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients
Jens Hoeppner, Katja Zirlik, Thomas Brunner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 3, 2013
Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy
Frank Makowiec, Peter Baier, Birte Kulemann, et al.
Page
of 5